Form 4: Spero Therapeutics CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Esther Rajavelu, CFO & CBO of Spero Therapeutics, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Esther Rajavelu, the CFO & CBO of Spero Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On February 3, 2025, Rajavelu acquired 266,139 shares of common stock through vesting restricted stock units (RSUs) at a price of $0.
- An additional 100,000 shares were acquired on the same day through vesting RSUs, also at $0.
- On February 5, 2025, Rajavelu sold 20,689 shares at $0.78 per share to cover tax withholding obligations related to the vesting of RSUs granted on February 1, 2024.
- Following these transactions, Rajavelu beneficially owns 724,720 shares of Spero Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and doesn't inherently indicate positive or negative sentiment regarding the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to track management's sentiment and potential alignment with shareholder interests.
Stakeholder Impact
- The sale of shares by an insider could be perceived negatively by some shareholders, although it is a common practice for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/01/2024 | Date of original RSU grant. |
| 02/03/2025 | Acquisition of common stock through RSU vesting. |
| 02/05/2025 | Sale of common stock to cover tax withholding obligations. |
| 02/03/2026 | First vesting date for RSUs acquired on February 3, 2025, in four equal annual installments. |
Keywords
Form 4, Beneficial Ownership, Spero Therapeutics, Rajavelu, RSU, Stock Sale, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.